Table 2 Mean level of satisfaction with each decision box of participating clinicians measured with a 5-point smiley-faces rating scale ranging from 1 (sad face) to 5 (smiling face)
Decision box clinical topics (abbreviations) | Mean level of satisfaction, range 1–5, 5 indicating higher satisfaction (± SD) | n |
|---|---|---|
The serum integrated test to screen women for fetal trisomy 21 (Prenatal) | 4.40 (0.85) | 67 |
The prostate-specific antigen test to screen men for prostate cancer (PSA) | 4.18 (0.87) | 51 |
Statins for primary prevention of cardiovascular disease (Statins) | 4.15 (0.78) | 56 |
Acetylsalicylic acid for primary prevention of cardiovascular disease (ASA) | 4.08 (0.94) | 67 |
The fecal occult blood test to screen for colorectal cancer (FOBT) | 4.07 (0.99) | 61 |
The BRCA1/2 gene mutation test to evaluate the risks of breast and ovarian cancer (BRCA) | 4.05 (0.94) | 63 |
Cholinesterase inhibitors to reduce the symptoms of Alzheimer’s disease (ChEIs) | 4.04 (0.99) | 74 |
Bisphosphonates to prevent osteoporotic fractures in postmenopausal women (OSTEO) | 3.98 (0.83) | 57 |